Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Shah Capital Management Acquires 1,544,263 Shares of Novavax, Inc. (NASDAQ:NVAX) | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Why Novavax is Gaining Ground in COVID-19 Vaccine Race | zacks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | 1.82 | 0.99 | -0.83 | -45.60% |
2024-05-10 | 2024-03 | -1.04 | -1.05 | -0.01 | -0.96% |
2024-02-28 | 2023-12 | -0.49 | -1.44 | -0.95 | -193.88% |
2023-11-09 | 2023-09 | -1.82 | -1.26 | 0.56 | 30.77% |
2023-08-08 | 2023-06 | -1.24 | 0.58 | 1.82 | 146.77% |
2023-05-09 | 2023-03 | -3.38 | -3.41 | -0.03 | -0.89% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-08 | B. Riley Securities | Upgrade | Neutral | Buy |
2023-05-09 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-28 | B. Riley Securities | Downgrade | Buy | Neutral |
2023-02-12 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-01 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-11 | ALTON GREGG H | Director | 10.47K | Conversion of Exercise of derivative security |
2024-06-11 | DOUGLAS RICHARD H | Director | 43.92K | Conversion of Exercise of derivative security |
2024-06-16 | DUBOVSKY FILIP | Officer | 66.61K | Sale |
2024-08-15 | KELLY JAMES PATRICK | Chief Financial Officer | 14.43K | Conversion of Exercise of derivative security |
2024-06-11 | KING RACHEL K | Director | 18.92K | Conversion of Exercise of derivative security |
2024-06-11 | MCGLYNN MARGARET G | Director | 10.47K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 11.68M | 86.78M | 12.37% |
2023-06-29 | Vanguard Group Inc | 10.57M | 78.55M | 11.20% |
2023-06-29 | Blackrock Inc. | 6.99M | 51.97M | 7.41% |
2023-09-29 | Shah Capital Management | 6.33M | 45.83M | 6.71% |
2023-06-29 | Bank of America Corporation | 2.18M | 16.23M | 2.31% |
2023-06-29 | Morgan Stanley | 2.08M | 15.46M | 2.20% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 9.38M | 75.07M | 9.94% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.64M | 19.60M | 2.79% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.23M | 16.56M | 2.36% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 16.10M | 2.13% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 1.28M | 9.48M | 1.35% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.21M | 8.98M | 1.28% |
Split | Date |
---|---|
1 : 20 | 2019-05-10 |
-
-
-
Can you please kick PAID Pumper AI Y out of the board?
-
$NVAX below vwap really? Sellers are so disappointing. Ok I’m done trying to help today. Holding. I’ll be back tomorrow.
-
-
$NVAX @Austin. What didn’t work was $MRNA and $PFE Gene therapies. This is an actual vaccine that takes time to produce and works like vaccines have in the past. Not just rushing through experimental options so Fauci can try and build a legacy before he’s out.
Scientist here for the long haul. But seriously some of y’all are annoying af with your lack of knowledge. @Juan there’s been plenty of news that warrant a bounce but shorts (and puts being exercised) are gonna make that hard till tomorrow. Maybe just google -
$NVAX technicals going up, ️ not down. Unless retail keep selling quantity 1, 2, 5, 7 pos shares. We see you. please stop.
-
$NVAX This would be a good place for some huge buy orders $96-$98 then hold past that resistance. Day bear trap.
-
$NVAX Shorts covering and trying to short again. If you had the program they use you would see that. STOP SELLING to them. For sake!
Some of y’all are so dumb saying shorts are in trouble. They aren’t. Not till about $135 are they in real trouble. Hold and it can rip past $135.
Some of y’all need to consider some education before you post nonsense because it doesn’t help new people when new stupid people post.
-
$NVAX It is a bull trap and WILL GO BACK DOWN because people keep selling. Supply and demand and supply is low factoring in shorts. If you’re selling you’re keeping it down. Don’t be that guy.
-
$NVAX Buy back do not sell. Shorts are counting on this $98 resistance so they can buy back and short again to bring it back down. Only way to make them cover it to drive it up. Stay the course. Solid fundamentals.
-
$NVAX it’s only resistance here if you are selling. Hold
-
$NVAXDo not sell. That’s how the shorts take it back down again. Hold.
-
$NVAX DO NOT PANIC SELL
If you don’t know about short sales you probably shouldn’t be trading.The shorts can’t win if you don’t sell them your shares at this discount they created. Fundamentals are solid. Stop selling and setting stops they will go straight for. Let shorts scramble to cover at higher prices.
-
You know how the shorts win? You sell them back your shares at the low price they need. They already started covering today. Longs know fundamentals are solid. Hold or else this keeps going down on good news.
-
I feel that $80 will be the turn around if there is one
-
$NVAX I spy some new positions!
https://finance.yahoo.com/news/selective-wealth-management-inc-buys-183830692.html
-
$NVAX In the market someone has to win and someone has to lose. But when shorts wreck a good thing on purpose, it secures their place in hell. Don’t forget we play a part too. They can only buy back at the lower prices if we sell to them.
-
For those of you who think $NVAX missed the party that $PFE and $MRNA came early to, you don’t understand that those are gene therapies. A traditional vaccine takes time to produce. We were there testing flu/covid combo shots when Fauci shut down the country to push his gene therapies and we are here now with the slow baked product. (You do know NIH owns 1/2 the Moderna patent Im sure.) It’s time, This is the real deal, not a crap shoot in the dark. If you had the gene therapies that don’t work, you can get the Novavax vaccine and stop the booster experiment.
-
$NVAX Soooo The Supreme Court blocked a tyrannical mandate that was never in place to begin with. So where’s the fire? Many people still want vaccines. This selloff is an over reaction and shorts are going to eat up the shares down to zero if we keep selling.
-
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
(NVAX) Trading Report
news.google.com • -
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Novavax Inc. stock underperforms Thursday when compared to competitors
news.google.com • -
Why Are Novavax Shares Trading Lower Today?
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)
seekingalpha.com • -
Novavax to Participate in Upcoming September Conferences
prnewswire.com • -
Novavax: Staying Long Despite Coming Up Short In Q2
seekingalpha.com • -
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
marketbeat.com • -
Novavax, Inc. (NVAX) Q2 2024 Earnings Call Transcript
seekingalpha.com •